These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 26894853

  • 1. Development and validation of an UPLC-MS/MS method for the quantification of irinotecan, SN-38 and SN-38 glucuronide in plasma, urine, feces, liver and kidney: Application to a pharmacokinetic study of irinotecan in rats.
    Basu S, Zeng M, Yin T, Gao S, Hu M.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar 15; 1015-1016():34-41. PubMed ID: 26894853
    [Abstract] [Full Text] [Related]

  • 2. Development and validation of an UPLC-MS/MS method for the determination of irinotecan (CPT-11), SN-38 and SN-38 glucuronide in human plasma and peritoneal tumor tissue from patients with peritoneal carcinomatosis.
    Gasthuys E, van Ovost J, Vande Casteele S, Cosyns S, Ceelen W, Van Bocxlaer J, Vermeulen A.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Feb 01; 1233():123980. PubMed ID: 38215697
    [Abstract] [Full Text] [Related]

  • 3. Determination of the sulfate and glucuronide conjugates of levornidazole in human plasma and urine, and levornidazole and its five metabolites in human feces by high performance liquid chromatography-tandem mass spectrometry.
    He G, Guo B, Zhang J, Li Y, Wu X, Fan Y, Chen Y, Cao G, Yu J.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr 01; 1081-1082():87-100. PubMed ID: 29518721
    [Abstract] [Full Text] [Related]

  • 4. Determination of irinotecan, SN-38 and SN-38 glucuronide using HPLC/MS/MS: Application in a clinical pharmacokinetic and personalized medicine in colorectal cancer patients.
    Atasilp C, Chansriwong P, Sirachainan E, Reungwetwattana T, Puangpetch A, Prommas S, Sirilerttrakul S, Rerkarmnuaychoke B, Wongwaisayawan S, Sukasem C.
    J Clin Lab Anal; 2018 Jan 01; 32(1):. PubMed ID: 28393405
    [Abstract] [Full Text] [Related]

  • 5. Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the simultaneous determination of irinotecan and its main metabolites in human plasma and its application in a clinical pharmacokinetic study.
    Marangon E, Posocco B, Mazzega E, Toffoli G.
    PLoS One; 2015 Jan 01; 10(2):e0118194. PubMed ID: 25689738
    [Abstract] [Full Text] [Related]

  • 6. A validated UPLC-MS/MS method to determine free and total irinotecan and its two metabolites in human plasma after intravenous administration of irinotecan hydrochloride liposome injection.
    Zhuang Q, Liu X, Sun Z, Wang H, Jiang J.
    J Pharm Biomed Anal; 2019 Jun 05; 170():112-123. PubMed ID: 30921645
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Determination of a novel nonfluorinated quinolone, nemonoxacin, in human feces and its glucuronide conjugate in human urine and feces by high-performance liquid chromatography-triple quadrupole mass spectrometry.
    He G, Guo B, Yu J, Zhang J, Wu X, Cao G, Shi Y, Tsai CY.
    Biomed Chromatogr; 2015 May 05; 29(5):739-48. PubMed ID: 25322721
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Quantitative determination of liposomal irinotecan and SN-38 concentrations in plasma samples from children with solid tumors: Use of a cryoprotectant solution to enhance liposome stability.
    Nair S, Selvo NS, Stolarski A, Klee B, Federico SM, Stewart CF.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Sep 15; 1245():124273. PubMed ID: 39146822
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Carboxylesterase and UDP-glucuronosyltransferases mediated metabolism of irinotecan: In vitro and in vivo insights from quantitative ultra-performance liquid chromatography-mass spectrometry analysis.
    Qin Y, Kang A, Zhou G, Wang H, Wei W, Cao Y, Chen Y, Wang J, Shi Y, Tang Y, Jiang J.
    Biomed Chromatogr; 2018 Oct 15; 32(10):e4320. PubMed ID: 29920713
    [Abstract] [Full Text] [Related]

  • 14. Simultaneous determination of three glucuronide conjugates of scutellarein in rat plasma by LC-MS/MS for pharmacokinetic study of breviscapine.
    Wang X, Xia H, Liu Y, Qiu F, Di X.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug 15; 965():79-84. PubMed ID: 24999248
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Development and validation of a UFLC-MS/MS method for determination of 7'(Z)-(8″S, 8‴S)-epi-salvianolic acid E, (7'R, 8'R, 8″S, 8‴S)-epi-salvianolic acid B and salvianolic acid B in rat plasma and its application to pharmacokinetic studies.
    Xie X, Sun W, Miao J, Huang J, Xu J, Liu X, Sun H, Tong L, Sun G.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun 01; 1022():6-12. PubMed ID: 27064533
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.